1. Home
  2. MOLN vs SMTI Comparison

MOLN vs SMTI Comparison

Compare MOLN & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.26

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$18.80

Market Cap

182.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOLN
SMTI
Founded
2004
1982
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
158.9M
182.6M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
MOLN
SMTI
Price
$4.26
$18.80
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$8.38
$41.00
AVG Volume (30 Days)
3.9K
52.8K
Earning Date
01-01-0001
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$20.66
Revenue Next Year
$318.52
$13.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.47
52 Week Low
$3.36
$18.29
52 Week High
$5.36
$35.70

Technical Indicators

Market Signals
Indicator
MOLN
SMTI
Relative Strength Index (RSI) 46.66 40.95
Support Level $3.51 $18.60
Resistance Level $4.63 $21.14
Average True Range (ATR) 0.28 0.99
MACD -0.09 -0.01
Stochastic Oscillator 34.92 7.63

Price Performance

Historical Comparison
MOLN
SMTI

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Share on Social Networks: